...
ocea-img

Ocean Biomedical Inc., Common Stock

OCEA

NAQ

$0.6641

+$0.08

(13.58%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$25.64M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
9.14M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.53
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.46 L
$7.79 H
$0.6641

About Ocean Biomedical Inc., Common Stock

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameOCEASectorS&P500
1-Week Return-1.76%-2.12%-3%
1-Month Return-3.75%-3.42%-0.73%
3-Month Return-28.59%-11.13%2.87%
6-Month Return-48.92%-5.74%7.17%
1-Year Return11.8%3.97%25.31%
3-Year Return-93.35%1.05%28.38%
5-Year Return-93.34%34.37%81.89%

Financials

Dec '19Dec '20Dec '21Dec '22
Total Revenue----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}]
Cost of Revenue----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}]
Gross Profit----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}]
Gross Margin----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}]
Operating Expenses232.00K1.65M62.34M2.48M[{"date":"2019-12-31","value":0.37,"profit":true},{"date":"2020-12-31","value":2.65,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":3.98,"profit":true}]
Operating Income(232.00K)(1.65M)(62.34M)(2.48M)[{"date":"2019-12-31","value":-23200000,"profit":false},{"date":"2020-12-31","value":-165200000,"profit":false},{"date":"2021-12-31","value":-6234500000,"profit":false},{"date":"2022-12-31","value":-248163900,"profit":false}]
Total Non-Operating Income/Expense---3.05M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true}]
Pre-Tax Income(232.00K)(1.65M)(62.34M)(958.43K)[{"date":"2019-12-31","value":-23200000,"profit":false},{"date":"2020-12-31","value":-165300000,"profit":false},{"date":"2021-12-31","value":-6234400000,"profit":false},{"date":"2022-12-31","value":-95843000,"profit":false}]
Income Taxes(171.86K)1.00K(1.00K)(1.52M)[{"date":"2019-12-31","value":-17186,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-100,"profit":false},{"date":"2022-12-31","value":-152390,"profit":false}]
Income After Taxes---565.47K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true}]
Income From Continuous Operations(232.00K)(1.65M)(62.34M)(958.43K)[{"date":"2019-12-31","value":-23200000,"profit":false},{"date":"2020-12-31","value":-165300000,"profit":false},{"date":"2021-12-31","value":-6234400000,"profit":false},{"date":"2022-12-31","value":-95843000,"profit":false}]
Income From Discontinued Operations----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true}]
Net Income(232.00K)(1.65M)(62.34M)565.47K[{"date":"2019-12-31","value":-41.03,"profit":false},{"date":"2020-12-31","value":-292.32,"profit":false},{"date":"2021-12-31","value":-11025.16,"profit":false},{"date":"2022-12-31","value":100,"profit":true}]
EPS (Diluted)--(0.04)(0.07)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-4,"profit":false},{"date":"2022-12-31","value":-6.9,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

OCEA
Cash Ratio 0.00
Current Ratio 0.07

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

OCEA
ROA (LTM) -681.99%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

OCEA
Debt Ratio Lower is generally better. Negative is bad. 17.50
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -16.50

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

OCEA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 100.67
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Ocean Biomedical Inc. share price today?

Ocean Biomedical Inc. (OCEA) share price today is $0.6641

Can Indians buy Ocean Biomedical Inc. shares?

Yes, Indians can buy shares of Ocean Biomedical Inc. (OCEA) on Vested. To buy Ocean Biomedical Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in OCEA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Ocean Biomedical Inc. be purchased?

Yes, you can purchase fractional shares of Ocean Biomedical Inc. (OCEA) via the Vested app. You can start investing in Ocean Biomedical Inc. (OCEA) with a minimum investment of $1.

How to invest in Ocean Biomedical Inc. shares from India?

You can invest in shares of Ocean Biomedical Inc. (OCEA) via Vested in three simple steps:

  • Click on Sign Up or Invest in OCEA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Ocean Biomedical Inc. shares
What is Ocean Biomedical Inc. 52-week high and low stock price?

The 52-week high price of Ocean Biomedical Inc. (OCEA) is $7.79. The 52-week low price of Ocean Biomedical Inc. (OCEA) is $0.46.

What is Ocean Biomedical Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Ocean Biomedical Inc. (OCEA) is

What is Ocean Biomedical Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Ocean Biomedical Inc. (OCEA) is 100.67

What is Ocean Biomedical Inc. dividend yield?

The dividend yield of Ocean Biomedical Inc. (OCEA) is 0.00%

What is the Market Cap of Ocean Biomedical Inc.?

The market capitalization of Ocean Biomedical Inc. (OCEA) is $25.64M

What is Ocean Biomedical Inc.’s stock symbol?

The stock symbol (or ticker) of Ocean Biomedical Inc. is OCEA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top